share

Methyl 7,8-Dihydroretinoate CAS NO 51077-51-1


Unit Price:

CAS No.:51077-51-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Methyl 7,8-Dihydroretinoate is a synthetic retinoid derivative, a modified form of vitamin A, offering enhanced stability for advanced research and development applications. This compound is valued for its role as a key intermediate in the synthesis of novel retinoids and for its utility in studying retinoid biology and signaling pathways. It is primarily sought by research institutions and pharmaceutical companies engaged in the development of dermatological treatments, oncology research, and other life science applications where precise molecular tools are required.

Application

  • Pharmaceutical Intermediate: A crucial building block in the synthesis of novel retinoid-based drugs targeting skin disorders, cancer, and other diseases.
  • Biochemical Research: Used as a stable analog in studies of retinoid receptor (RAR/RXR) activation, gene expression, and cellular differentiation.
  • Dermatological R&D: Serves as a precursor or model compound for developing new topical formulations aimed at treating acne, psoriasis, and photoaging.
  • Cosmeceutical Ingredient Development: Investigated for potential use in advanced anti-aging and skin-repair cosmetic formulations.
  • Reference Standard: Employed as an analytical standard in quality control laboratories for HPLC or LC-MS methods to identify and quantify related compounds.
  • Chemical Synthesis: Utilized in organic synthesis to create libraries of retinoid analogs for structure-activity relationship (SAR) studies.

Basic Information

Product Name Methyl 7,8-Dihydroretinoate
CAS No. 51077-51-1
Molecular Formula C21H30O2
Molecular Weight 314.47 g/mol
Synonyms Methyl 7,8-Dihydroretinoate; Methyl (all-E)-7,8-Dihydroretinoate; Retinoic acid, 7,8-dihydro-, methyl ester; Methyl 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate (7,8-dihydro); 7,8-Dihydroretinoic acid methyl ester; Methyl ester of 7,8-dihydroretinoic acid
EINECS Contact for details

Quality Control

Our Methyl 7,8-Dihydroretinoate is produced under strict quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and development. A Certificate of Analysis (COA) detailing specific results is provided with every shipment. We support compliance with relevant research and development guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen or argon) at controlled room temperature (15-25°C) to minimize oxidation and degradation. Keep the container in a cool, dry, and well-ventilated place away from incompatible materials.

Specification

Item Specification
Appearance Yellow to orange crystalline powder or solid
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0%
Solubility Soluble in DMSO, DMF; sparingly soluble in alcohols

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.